{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:54:15Z","timestamp":1764168855787,"version":"3.46.0"},"reference-count":52,"publisher":"Informa UK Limited","issue":"25","license":[{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031585","name":"Takeda Development Center Americas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031585","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,10,21]]},"DOI":"10.1080\/14796694.2025.2565497","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:31:47Z","timestamp":1759732307000},"page":"3329-3342","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Oncologists\u2019 preferences for frontline TKI treatment of Ph+ acute lymphoblastic leukemia: a discrete choice experiment"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3731-0769","authenticated-orcid":false,"given":"Ajibade","family":"Ashaye","sequence":"first","affiliation":[{"name":"Takeda Development Center Americas, Inc","place":["Cambridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9291-1511","authenticated-orcid":false,"given":"Matthew","family":"Quaife","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyu","family":"Wu","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Inc","place":["Cambridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1319-5161","authenticated-orcid":false,"given":"\u00c1lvaro Alberto","family":"Guti\u00e9rrez-Vargas","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Jiongco","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5290-9289","authenticated-orcid":false,"given":"Vamsi","family":"Kota","sequence":"additional","affiliation":[{"name":"Augusta University","place":["Augusta, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-9965","authenticated-orcid":false,"given":"Bipin","family":"Savani","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Inc","place":["Cambridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-714X","authenticated-orcid":false,"given":"Caitlin","family":"Thomas","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000532"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2023.103392"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-012-0247-7"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071805"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22206"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000338"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2113347"},{"key":"e_1_3_9_10_1","unstructured":"Takeda [Internet]. Takeda announces U.S. FDA approval of supplemental new drug application (sNDA) for ICLUSIG\u00ae (ponatinib) in adult patients with newly diagnosed Ph+ ALL. 2024 [cited 2024 Aug 30]. Available from: https:\/\/www.takeda.com\/newsroom\/newsreleases\/2024\/takeda-announces-us-fda-approval-of-drug-for-iclusig-ponatinib-in-adult-patients\/"},{"key":"e_1_3_9_11_1","unstructured":"U.S. Food and Drug Administration (FDA) [Internet]. Highlights of prescribing information: iclusig\u00ae (ponatinib) tablets for oral use. 2024 [cited 2025 Mar 18]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/203469s037lbl.pdf"},{"key":"e_1_3_9_12_1","unstructured":"U.S. Food and Drug Administration (FDA) [Internet]. Highlights of prescribing information: gleevec\u00ae (imatinib mesylate) tablets for oral use. 2022 [cited 2024 Sep 10]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/021588s062lbl.pdf"},{"key":"e_1_3_9_13_1","unstructured":"U.S. Food and Drug Administration (FDA) [Internet]. Highlights of prescribing information: sprycel (dasatinib) tablet for oral use. 2006 [cited 2025 Mar 18]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021986s013lbl.pdf"},{"key":"e_1_3_9_14_1","unstructured":"U.S. Food and Drug Administration (FDA) [Internet]. Highlights of prescribing information: Tasigna\u00ae (nilotinib) capsules for oral use. 2024 [cited 2024 Sep 10]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/022068s041lbl.pdf"},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.4783"},{"key":"e_1_3_9_16_1","unstructured":"U.S. Food and Drug Administration (FDA) [Internet]. FDA grants accelerated approval to ponatinib with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. 2024 [cited 2024 Mar 25]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-ponatinib-chemotherapy-newly-diagnosed-philadelphia-chromosome"},{"key":"e_1_3_9_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02497-y"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-021-00520-4"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112736"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0734-2"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0082"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2223"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.013"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-024-01431-6"},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70175"},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.04.014"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179645"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(20)30459-6"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.07.021"},{"key":"e_1_3_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.217"},{"key":"e_1_3_9_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826080-00004"},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.2196\/32365"},{"key":"e_1_3_9_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-020-00276-x"},{"key":"e_1_3_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00133443"},{"key":"e_1_3_9_35_1","first-page":"218","volume-title":"Economic information, decision, and prediction: selected essays: volume I part I economics of decision","author":"Marschak J","year":"1960","unstructured":"Marschak J, Binary-Choice Constraints and Random Utility Indicators. Economic information, decision, and prediction: selected essays: volume I part I economics of decision. Dordrecht: Springer Netherlands; 1960. p. 218\u2013239."},{"key":"e_1_3_9_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-13-61"},{"key":"e_1_3_9_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/21606544.2018.1515118"},{"key":"e_1_3_9_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/erae\/jbaa024"},{"key":"e_1_3_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.04.004"},{"key":"e_1_3_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.03.009"},{"key":"e_1_3_9_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S010"},{"key":"e_1_3_9_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14240"},{"key":"e_1_3_9_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70177"},{"key":"e_1_3_9_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-024-00510-w"},{"key":"e_1_3_9_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-024-00344-z"},{"key":"e_1_3_9_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000413"},{"key":"e_1_3_9_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26816"},{"key":"e_1_3_9_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33529"},{"key":"e_1_3_9_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.1229"},{"key":"e_1_3_9_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-015700"},{"key":"e_1_3_9_51_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.2.247"},{"key":"e_1_3_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00434-0"},{"key":"e_1_3_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12507"},{"key":"e_1_3_9_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.24.00262"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2565497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:49:29Z","timestamp":1764168569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2565497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":52,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025,10,21]]}},"alternative-id":["10.1080\/14796694.2025.2565497"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2565497","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"type":"print","value":"1479-6694"},{"type":"electronic","value":"1744-8301"}],"subject":[],"published":{"date-parts":[[2025,10,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}